The molecular mechanism, targets, and novel molecules in the treatment of Alzheimer’s disease
- 1 February 2022
- journal article
- research article
- Published by Elsevier in Bioorganic Chemistry
- Vol. 119, 105562
Abstract
No abstract availableKeywords
This publication has 147 references indexed in Scilit:
- Linking lipids to Alzheimer's disease: cholesterol and beyondNature Reviews Neuroscience, 2011
- Vascular basis for brain degeneration: faltering controls and risk factors for dementiaNutrition Reviews, 2010
- Post-Stroke Inhibition of Induced NADPH Oxidase Type 4 Prevents Oxidative Stress and NeurodegenerationPLOS Biology, 2010
- The secretases: enzymes with therapeutic potential in Alzheimer diseaseNature Reviews Neurology, 2010
- The β-Secretase Enzyme BACE in Health and Alzheimer's Disease: Regulation, Cell Biology, Function, and Therapeutic PotentialThe Journal of Neuroscience, 2009
- The Role of Apolipoprotein E in Alzheimer's DiseaseNeuron, 2009
- Alpha- and beta-secretase activity as a function of age and beta-amyloid in Down syndrome and normal brainNeurobiology of Aging, 2007
- Loss‐of‐function presenilin mutations in Alzheimer diseaseEMBO Reports, 2007
- The role of acetylcholine in learning and memoryCurrent Opinion in Neurobiology, 2006
- Oxidative stress and neurodegeneration: where are we now?Journal of Neurochemistry, 2006